Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison Cave

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
BMJ Open|September 7, 2018
Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulationAlexandra Pacurariu, Kelly Plueschke, Patricia McGettigan, et al.
Clinical Pharmacology and Therapeutics|April 4, 2020
Different Strategies to Execute Multi-Database Studies for Medicines Surveillance in Real-World Setting: A Reflection on the European ModelRona Gini, Miriam C J Sturkenboom, Janet Sultana, et al.
Nature Reviews. Drug Discovery|December 8, 2021
Choosing drugs for UK COVID-19 treatment trialsPatrick F Chinnery, Marion Bonnet, Alison Cave, et al.
Pharmacoepidemiology and Drug Safety|October 9, 2025
Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal ManagementG Niklas Norén, Katherine Donegan, Monica A Muñoz, et al.
Pharmacoepidemiology and Drug Safety|October 16, 2024
Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of FluoroquinolonesYuchen Guo, Berta Raventós, Martí Català, et al.
British Journal of Clinical Pharmacology|March 13, 2020
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicinesJane Moseley, Spiros Vamvakas, Michael Berntgen, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
BMJ Open|September 7, 2018
Electronic healthcare databases in Europe: descriptive analysis of characteristics and potential for use in medicines regulationAlexandra Pacurariu, Kelly Plueschke, Patricia McGettigan, et al.
Clinical Pharmacology and Therapeutics|April 4, 2020
Different Strategies to Execute Multi-Database Studies for Medicines Surveillance in Real-World Setting: A Reflection on the European ModelRona Gini, Miriam C J Sturkenboom, Janet Sultana, et al.
Nature Reviews. Drug Discovery|December 8, 2021
Choosing drugs for UK COVID-19 treatment trialsPatrick F Chinnery, Marion Bonnet, Alison Cave, et al.
Pharmacoepidemiology and Drug Safety|October 9, 2025
Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal ManagementG Niklas Norén, Katherine Donegan, Monica A Muñoz, et al.
Pharmacoepidemiology and Drug Safety|October 16, 2024
Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of FluoroquinolonesYuchen Guo, Berta Raventós, Martí Català, et al.
British Journal of Clinical Pharmacology|March 13, 2020
Regulatory and health technology assessment advice on postlicensing and postlaunch evidence generation is a foundation for lifecycle data collection for medicinesJane Moseley, Spiros Vamvakas, Michael Berntgen, et al.
Pageof 2